Pharming (PHAR) Cost of Revenue (2020 - 2026)
Pharming's Cost of Revenue came in at $15.40 for Q3 2026, up 116.9% from $7.10 a year earlier but down 100.0% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Cost of Revenue (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Pharming reported Cost of Revenue of $27.83 million, up 8.6% year-over-year; for FY2025, it came in at $45.5 million, up 28.5% from FY2024.
- Cost of Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
- Going back by year, Cost of Revenue was $35.4 million in FY2024 (+40.4%), $25.21 million in FY2023 (+43.6%), $17.56 million in FY2022 (-16.9%) and $21.14 million in FY2021 (-10.2%).
- The five-year range for quarterly Cost of Revenue is $7.10 (Q3 2025) to $50.1 million (Q2 2022).
- Year-over-year, Cost of Revenue increased in four of the last eight quarters, with an average decline of 0.4%.
- The fastest year-over-year change in Cost of Revenue over five years came in Q2 2022 (growth of 992.2%), and the weakest in Q3 2025 (a decline of 100.0%).
- Business Quant data shows PHAR's Cost of Revenue at $21.19 million (Q2 2026), $6.64 million (Q1 2026) and $21.10 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Pharming | 927.62 Mn | 229.29 Mn | 102.20 | 15.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.40 |
| Jun 30, 2026 | 21.19 Mn |
| Mar 31, 2026 | 6.64 Mn |
| Dec 31, 2025 | 21.10 |
| Sep 30, 2025 | 7.10 |
| Jun 30, 2025 | 17.30 Mn |
| Mar 31, 2025 | 8.32 Mn |
| Dec 31, 2024 | 12.20 |
| Sep 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 16.37 Mn |
| Mar 31, 2024 | 8.39 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 8.30 Mn |
| Jun 30, 2023 | 9.80 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 50.10 Mn |
| Mar 31, 2022 | 4.90 Mn |
| Dec 31, 2021 | 21.13 Mn |
API Access
Pharming Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();